Trends in age and anthropometric data at start of growth hormone treatment for girls with turner syndrome in Japan

Endocrine Journal

Volumn 55, Issue 6, 2008, Pages 1065-1070

  Isojima, Tsuyoshi ^a   Yokoya, Susumu ^a,c   Ito, Junko ^b,c   Horikawa, Reiko ^a,c   Tanaka, Toshiaki ^c,d  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c Foundation for Growth Science   (Japan)

^d Tanaka Growth Clinic   (Japan)

Author keywords

Diagnosis delay; Growth failure; Growth hormone; Turner syndrome

Indexed keywords

GROWTH HORMONE;

ANTHROPOMETRY; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HORMONAL THERAPY; HUMAN; JAPAN; KARYOTYPE 45,X; MAJOR CLINICAL STUDY; ONSET AGE; PRESCHOOL CHILD; SCHOOL CHILD; TURNER SYNDROME;

ADOLESCENT; AGE DISTRIBUTION; BODY WEIGHTS AND MEASURES; CHILD; COHORT STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; JAPAN; RETROSPECTIVE STUDIES; TIME FACTORS; TURNER SYNDROME;

EID: 58549094713     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-144     Document Type: Article

References (30)

1. Saenger P (1996) Turner's syndrome. N Engl J Med 335: 1749-1754.
2. Ranke MB, Grauer ML (1993) Adult height in Turner syndrome: results of multinational survey 1993. Horm Res 42: 90-94.
3. Baxter L, Bryant J, Cave CB, Milne R (2007) Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev Jan 24; (1): CD003887. Review.
4. Frías JL, Davenport ML, Committee on Genetics and Section on Endocrinology (2003) Health supervision for children with Turner syndrome. Pediatrics 111: 692-702.
5. Bondy CA for The Turner Syndrome Consensus Study Group (2007) Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group. J Clin Endocrinol Metab 92: 10-25.
6. Quigley CA, Crowe BJ, Anglin DG, Chipman JJ, The U.S. Turner syndrome study group (2002) Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 87: 2033-2041.
7. Van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TCJ, Jansen M, Otten BJ, Hoorweg-Nijman JJG, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SLS (2003) Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 88: 1119-1125.
8. Canadian Growth Hormone Advisory Committee (2005) Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadean randomized control trial. J Clin Endocrinol Metab 90: 3360-3366.
9. Ranke MB, Partsch CJ, Lindberg A, Dörr HG, Bettendori M, Hauffa BP, Schwarz HP, Mehls O, Sander S, Stahnke N, Steinkamp H, Said E, Sippell W (2002) Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-Up Study 2001. Eur J Endocrinol 147: 625-633.
10. Pasquino AM, Pucarelli I, Segni M, Tarani L, Calcaterra V, Larrizza D (2005) Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group. J Endocrinol Invest 28: 350-356.
11. Soriano-Guillen L, Coste J, Ecosse E, Léger J, Tauber M, Cabrol S, Nicolino M, Brauner R, the StaTur Study Group, Chaussain JL, Carel JC (2005) Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J Clin Endocrinol Metab 90: 5197-5204.
12. Reiter EO, Blethen SL, Baptista J, Price L. (2001) Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome. J Clin Endocrinol Metab 86: 1936-1941.
13. Wasniewsla M, De Luca F, Bergamaschi R, Guarneri MP, Mazzanti L, Matarazzo P, Petri A, Crisafulli G, Salzano G, Lombardo F (2004) Early treatment with GH alone in Turner syndrome: prepubertal catch-up growth and waning effect. Eur J Endocrinol 151: 567-572.
14. Ranke MB, Lindberg A, Longás AF, Darendellier F, Albertsson-Wikland K, Dunger D, Cutfield WS, Tauber M, Wilton P, Wollmann HA, Reiter EO (2007) Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Pediatr Res 67: 105-110.
15. Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, Gunther DF, Liu C, Geffner ME, Thrailkill K, Huseman C, Zagar AJ, Quigley CA (2007) Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab 92: 3406-3416.
16. Betts PR, Butler GE, Donaldson MDC, Dunger DB, Johonston DI, Kelnar CJH, Krik J, Price DA, Wilton P (1999) A decade of growth hormone treatment in girls with Turner syndrome in the UK. UK KIGS Executive Group. Arch Dis Child 80: 221-225.
17. Massa G, Verlinde F, De Schepper J, Thomas M, Bourguignon JP, Craen M, de Zegher F, Francois I, Du Caju M, Maes M, Heinrichs C; the Belgian Study Group for Paediatric Endocrinology (2005) Trends in age at diagnosis of Turner syndrome. Arch Dis Child 90: 267-268.
18. Gravholt CH (2004) Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 151: 657-687.
19. Sävendahl L, Davenport ML (2000) Delayed diagnoses of Turner's syndrome: proposed guidelines for change. J Pediatr 137: 455-459.
20. Sybert VP, McCauley E (2004) Turner's syndrome. N Engl J Med 351: 1227-1238.
21. Tanaka T, Takano K, Hanew K, Nishi Y, Igarashi Y, Hirano T, Saito T, Tachibana K, Yokoya S, Fujieda K, Shimatsu A, Hizuka N, Tsushima T, Irie M (1998) Registration system for growth hormone(GH) treatment with standardized immunoreactive GH values in Japan. Endocr J 45: 459-465.
22. Gu YH, Kato T, Harada S, Sato Y, Kakee N (2008) Medical aid program for chronic pediatric diseases of specified categories in Japan: Current status and future prospects. Pediatr Int 50: 376-387.
23. Fujieda K (2004) Medical aid program for chronic pediatric disease of specified categories in Japan available online at: http: //www.pediatric-world. com/asahikawa/2007symaken/index.html Accessed June 23, 2008.
24. Massa G, Vanderschueren-Lodeweyckx M (1991) Age and height at diagnosis in Turner syndrome: influence of parental height. Pediatrics 88: 1148-1152.
25. Suwa S, Tachibana K (1993) Standard growth charts for height and weight of Japanese children from birth to 17 years based on a cross-sectional survey of national data. Clin Pediatr Endocrinol 2: 87-97.
26. Suwa S (1992) Standards for growth and growth velocity in Turner's syndrome. Acta Paediatr Jpn 34: 206-221.
27. Inokuchi M, Hasegawa T, Anzo M, Matsuo N (2006) Standardized centile curves of body mass index for Japanese children and adolescents based on the 1978-1981 national survey date. Ann Hum Biol 33: 444-453.
28. Tanaka T, Hibi I, Shizume K (1991) GH-secretion capacity in Turner syndrome and its relations to clinical characteristics and effect of GH treatment - a comparison with pituitary dwarfism -. Folia Endocrinol 67: 597-610 [in Japanese].
29. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH (2006) Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 91: 3897-3902.
30. Ostberg JE, Conway GS (2003) Adulthood in women with Turner syndrome. Horm Res 59: 211-221.